This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Charles H. Kellner, MD; Mark D. Beale, MD; John T. Pritchett, MD
Medical University of South Carolina Charleston

JAMA. 1994;271(23):1828.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The excellent article by Cohen et al¹ does much to dispel fears about the risks of lithium carbonate during pregnancy. We would like to point out that in addition to carbamazepine, valproate sodium, and neuroleptics, electroconvulsive therapy (ECT) should be considered as an antimanic and antidepressant treatment during pregnancy. In fact, most experts consider ECT to be safer for the fetus than many psychotropic medications,² and there is an extensive literature documenting the safe and effective use of ECT in all three trimesters.³ The brief exposure to the anesthetic and muscle relaxant agents during ECT is likely to be more benign than constant exposure to (even slightly) teratogenic psychotropic medications. For severely depressed or manic pregnant women, ECT should be considered seriously. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?